Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with st rd paclitaxel (P) in patients (pts) with 1 - to 3 -line metastatic HER2-negative breast cancer (BC) Monica Mita,1 Carlos Becerra,2 Dona - HER2 neu - Document - PDFSEARCH.IO

First Page	Meta Content
	Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with st rd paclitaxel (P) in patients (pts) with 1 - to 3 -line metastatic HER2-negative breast cancer (BC) Monica Mita,1 Carlos Becerra,2 Dona Add to Reading List Document Date: 2016-06-05 05:56:31 Open Document File Size: 672,91 KB Share Result on Facebook

Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with st rd paclitaxel (P) in patients (pts) with 1 - to 3 -line metastatic HER2-negative breast cancer (BC) Monica Mita,1 Carlos Becerra,2 DonaAdd to Reading List